Omrix Biopharmaceuticals Ltd.
USPTO PatentsView assignee record - 85 granted patents across 26 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61K (Preparations FOR Medical, Dental OR Toiletry Purposes).
The verdict
According to USPTO PatentsView, Omrix ranks #4,214 of 49,997 tracked US assignees by granted-patent volume, with 85 patents across 26 technology areas.
- #4,214
- of 49,997 US assignees by volume
- Top 24%
- by Innovation Score (45.1/100)
- 10.1
- avg claims per patent
- -5%
- grant velocity, last 5 yrs
USPTO PatentsView assignee plate
Corpus R4214 · Foreign Corporation #4,214 · 85 grants
GRANTS-SMALL · TOP-DECILE · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-PAR · TYPE-FRNCORP · VEL-FLAT · BOOK-FULL
- GRANTS-SMALL 85 grants
- TOP-DECILE #4,214/49,997
- PHOTO-FINISH Nobel Biocare Services
- CPC-FOCUS A61K · 26 areas
- INNOV-PAR 45.1/100
- CLAIMS-PAR 10.1 claims/avg
- TYPE-FRNCORP Foreign Corp
- VEL-FLAT -5% vel
- BOOK-FULL 10/10 fields
Nearest grant-volume peer: Nobel Biocare Services AG (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
How Omrix’s 45.1 Innovation Score adds up
The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.
Innovation-score neighbourhood around Omrix
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
- Qualcomm Incorporated · highest
Qualcomm Incorporated · highest
85 score
- Academisch Ziekenhui… · near
Academisch Ziekenhui… · near
45 score
- Bracco Imaging S P A · near
Bracco Imaging S P A · near
45 score
- La-Z-Boy Incorporated · near
La-Z-Boy Incorporated · near
45 score
- Omrix Biopharmaceuti… · this assignee
Omrix Biopharmaceuti… · this assignee
45 score
- Withings · near
Withings · near
45 score
- 3D Lighting… · lowest 7
3D Lighting… · lowest
7 score
What this shows Omrix's Innovation Score is 45.1/100 (top 24% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Does more volume mean deeper claims for Omrix?
Each dot is one of Omrix’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Omrix’s own 10.1 claims/patent is at or below the 16.0 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.
Where Omrix's grants concentrate
Omrix Biopharmaceuticals Ltd. is a focused PatentsView assignee: 26 CPC subclasses with 55.3% of grants classified under A61K (Preparations FOR Medical, Dental OR Toiletry Purposes). Peak complete grant year is 2018 (15 grants) versus a trough of 5 in 2017. By volume, Omrix sits between NV Bekaert SA and Rotation Medical, Inc..
Omrix's three-year grant acceleration
From 2019–2021 to 2022–2024, Omrix Biopharmaceuticals Ltd. moved from 25 to 21 grants (0.84x the prior three-year total, a multiple, not a CAGR). See the growth leaderboard.
Who files at Omrix's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- Bekaert
NV Bekaert SA
85 patents
- Nobel Biocare Ser…
Nobel Biocare Services AG
85 patents
- O&M Halyard
O&M Halyard, Inc.
85 patents
- Océ Holding B V
Océ Holding B.V.
85 patents
- Otto Bock Healthc…
Otto Bock Healthcare LP
85 patents
- Pindrop Security
Pindrop Security, Inc.
85 patents
- Polygroup Macau (…
Polygroup Macau Limited (BVI)
85 patents
- Rotation Medical
Rotation Medical, Inc.
85 patents
- Omrix Biopharmace… ◀
Omrix Biopharmaceuticals Ltd.
85 patents
What this shows Omrix holds 85 patents at rank #4,214, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near Omrix
By rank, the assignees closest to #4,214 in granted patent volume.
- NV Bekaert SA #4,210 · 85 patents
- Nobel Biocare Services AG #4,211 · 85 patents
- O&M Halyard, Inc. #4,212 · 85 patents
- Océ Holding B.V. #4,213 · 85 patents
- Otto Bock Healthcare LP #4,215 · 85 patents
- Pindrop Security, Inc. #4,216 · 85 patents
- Polygroup Macau Limited (BVI) #4,217 · 85 patents
- Rotation Medical, Inc. #4,218 · 85 patents
Leaders in A61K (Preparations FOR Medical)
Other assignees with the most granted patents in Omrix's primary technology class.
- The Regents of the University of California 1,779 in class
- L'Oreal 1,250 in class
- Novartis AG 988 in class
- The Procter & Gamble Company 985 in class
- The Board of Regents of the University of Texas System 950 in class
- The United States of America, as represented by the Secretary, Department of Health and Human Services 813 in class
- The Trustees of the University of Pennsylvania 768 in class
- Merck Sharp & Dohme LLC 760 in class
Assignees with similar portfolio profiles
Two PlainPatent-derived peer sets for Omrix, neither rank-band nor same-CPC leaders (those blocks stay above). In A61K (Preparations FOR Medical), Omrix ranks #474 of 7,163 assignees by patent count in that subclass.
Similar innovation score
Nearest assignees by Innovation Score (45 here).
Similar claim depth
Nearest assignees by average claims per patent (10.1 here).
Omrix's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
45 Top 24% higher than 76% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 8 | 9.4% |
| 2016 | 8 | 9.4% |
| 2017 | 5 | 5.9% |
| 2018 | 15 | 17.6% |
| 2019 | 6 | 7.1% |
| 2020 | 7 | 8.2% |
| 2021 | 12 | 14.1% |
| 2022 | 5 | 5.9% |
| 2023 | 6 | 7.1% |
| 2024 | 10 | 11.8% |
| 2025partial year | 3 | 3.5% |
Which technologies does Omrix Biopharmaceuticals Ltd. patent most?
Top 15 of 26 technology areas
Data Source
USPTO PatentsView, US granted patents 2015–2025
What to do with this data
Omrix Biopharmaceuticals Ltd.'s patent record in context - here's where to go next.
- Omrix Biopharmaceuticals Ltd.'s lead technology class is A61K (Preparations FOR Medical, Dental OR Toiletry Purposes), 55.3% of its portfolio - see every assignee active in that class. Explore A61K
- Ranked #4,214 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
- Compare Omrix Biopharmaceuticals Ltd. against NV Bekaert SA, an assignee filing at a similar volume. Compare portfolios
- Innovation Score of 45.1/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.